214 related articles for article (PubMed ID: 31566112)
21. Clinical pharmacy in onco-hematology and bone marrow transplant: A valuable contribution to improving patient safety.
Visacri MB; Tavares MG; Barbosa CR; Duarte NC; Moriel P
J Oncol Pharm Pract; 2021 Jul; 27(5):1172-1180. PubMed ID: 32715916
[TBL] [Abstract][Full Text] [Related]
22. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
[No Abstract] [Full Text] [Related]
23. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
[TBL] [Abstract][Full Text] [Related]
24. A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.
Kessemeier N; Meyn D; Hoeckel M; Reitze J; Culmsee C; Tryba M
Int J Clin Pharm; 2019 Oct; 41(5):1184-1192. PubMed ID: 31332648
[TBL] [Abstract][Full Text] [Related]
25. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
[TBL] [Abstract][Full Text] [Related]
26. The incidence and severity of errors in pharmacist-written discharge medication orders.
Onatade R; Sawieres S; Veck A; Smith L; Gore S; Al-Azeib S
Int J Clin Pharm; 2017 Aug; 39(4):722-728. PubMed ID: 28573438
[TBL] [Abstract][Full Text] [Related]
27. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
28. Impact of pharmacist interventions on medication errors in hospitalized pediatric patients: a systematic review and meta-analysis.
Naseralallah LM; Hussain TA; Jaam M; Pawluk SA
Int J Clin Pharm; 2020 Aug; 42(4):979-994. PubMed ID: 32328958
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of clinical pharmacist interventions in paediatric hospital patients.
Drovandi A; Robertson K; Tucker M; Robinson N; Perks S; Kairuz T
Eur J Pediatr; 2018 Aug; 177(8):1139-1148. PubMed ID: 29915870
[TBL] [Abstract][Full Text] [Related]
30. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
[TBL] [Abstract][Full Text] [Related]
31. Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.
Jermini M; Fonzo-Christe C; Blondon K; Milaire C; Stirnemann J; Bonnabry P; Guignard B
Int J Clin Pharm; 2024 Apr; 46(2):496-505. PubMed ID: 38315303
[TBL] [Abstract][Full Text] [Related]
32. Implementation and evaluation of a collaborative clinical pharmacist's medications reconciliation and charting service for admitted medical inpatients in a metropolitan hospital.
Khalil V; deClifford JM; Lam S; Subramaniam A
J Clin Pharm Ther; 2016 Dec; 41(6):662-666. PubMed ID: 27578624
[TBL] [Abstract][Full Text] [Related]
33. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
[TBL] [Abstract][Full Text] [Related]
34. Clinical and economic impact of pharmacist interventions on sampled outpatient prescriptions in a Chinese teaching hospital.
Bao Z; Ji C; Hu J; Luo C; Fang W
BMC Health Serv Res; 2018 Jul; 18(1):519. PubMed ID: 29973200
[TBL] [Abstract][Full Text] [Related]
35. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
[TBL] [Abstract][Full Text] [Related]
36. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
37. Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations.
Luo H; Fan Q; Xiao S; Chen K
PLoS One; 2017; 12(10):e0186302. PubMed ID: 29045435
[TBL] [Abstract][Full Text] [Related]
38. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
[TBL] [Abstract][Full Text] [Related]
39. Transformation of a pharmacy department: impact on pharmacist interventions, error prevention, and cost.
Crowson K; Collette D; Dang M; Rittase N
Jt Comm J Qual Improv; 2002 Jun; 28(6):324-30. PubMed ID: 12066624
[TBL] [Abstract][Full Text] [Related]
40. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
